JP4550587B2 - 熱安定性α−アミラーゼ - Google Patents
熱安定性α−アミラーゼ Download PDFInfo
- Publication number
- JP4550587B2 JP4550587B2 JP2004559633A JP2004559633A JP4550587B2 JP 4550587 B2 JP4550587 B2 JP 4550587B2 JP 2004559633 A JP2004559633 A JP 2004559633A JP 2004559633 A JP2004559633 A JP 2004559633A JP 4550587 B2 JP4550587 B2 JP 4550587B2
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- amylase activity
- amylase
- bacillus
- polynucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108090000637 alpha-Amylases Proteins 0.000 title claims abstract description 119
- 102000004139 alpha-Amylases Human genes 0.000 title claims abstract description 116
- 229940024171 alpha-amylase Drugs 0.000 title claims abstract description 110
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 120
- 229920001184 polypeptide Polymers 0.000 claims abstract description 117
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 117
- 230000000694 effects Effects 0.000 claims abstract description 82
- 108091033319 polynucleotide Proteins 0.000 claims abstract description 59
- 102000040430 polynucleotide Human genes 0.000 claims abstract description 59
- 239000002157 polynucleotide Substances 0.000 claims abstract description 59
- 239000002773 nucleotide Substances 0.000 claims abstract description 44
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 44
- 150000001413 amino acids Chemical class 0.000 claims abstract description 35
- 239000012634 fragment Substances 0.000 claims abstract description 10
- 108700026244 Open Reading Frames Proteins 0.000 claims abstract description 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 6
- 238000000034 method Methods 0.000 claims description 76
- 229920002472 Starch Polymers 0.000 claims description 35
- 239000008107 starch Substances 0.000 claims description 34
- 235000019698 starch Nutrition 0.000 claims description 34
- 238000004519 manufacturing process Methods 0.000 claims description 26
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 17
- 241000193744 Bacillus amyloliquefaciens Species 0.000 claims description 17
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 17
- 238000006243 chemical reaction Methods 0.000 claims description 17
- 239000013604 expression vector Substances 0.000 claims description 17
- 239000006188 syrup Substances 0.000 claims description 17
- 235000020357 syrup Nutrition 0.000 claims description 17
- 150000007523 nucleic acids Chemical class 0.000 claims description 16
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 14
- 102000039446 nucleic acids Human genes 0.000 claims description 14
- 108020004707 nucleic acids Proteins 0.000 claims description 14
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 8
- 241000233866 Fungi Species 0.000 claims description 8
- 238000012217 deletion Methods 0.000 claims description 8
- 230000037430 deletion Effects 0.000 claims description 8
- 244000063299 Bacillus subtilis Species 0.000 claims description 7
- 241000193385 Geobacillus stearothermophilus Species 0.000 claims description 7
- 238000006467 substitution reaction Methods 0.000 claims description 7
- 239000004744 fabric Substances 0.000 claims description 6
- 238000003780 insertion Methods 0.000 claims description 6
- 230000037431 insertion Effects 0.000 claims description 6
- 241000194108 Bacillus licheniformis Species 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 238000003259 recombinant expression Methods 0.000 claims description 5
- 241000193752 Bacillus circulans Species 0.000 claims description 4
- 241000193749 Bacillus coagulans Species 0.000 claims description 4
- 241000193388 Bacillus thuringiensis Species 0.000 claims description 4
- 241000894006 Bacteria Species 0.000 claims description 4
- 241000193764 Brevibacillus brevis Species 0.000 claims description 4
- 229940054340 bacillus coagulans Drugs 0.000 claims description 4
- 229940097012 bacillus thuringiensis Drugs 0.000 claims description 4
- 238000012258 culturing Methods 0.000 claims description 4
- 238000009990 desizing Methods 0.000 claims description 4
- 244000005700 microbiome Species 0.000 claims description 4
- 241000193422 Bacillus lentus Species 0.000 claims description 3
- 229920000881 Modified starch Polymers 0.000 claims description 2
- 239000004368 Modified starch Substances 0.000 claims description 2
- 241000194109 Paenibacillus lautus Species 0.000 claims description 2
- 238000000855 fermentation Methods 0.000 claims description 2
- 230000004151 fermentation Effects 0.000 claims description 2
- 235000019426 modified starch Nutrition 0.000 claims description 2
- 239000004382 Amylase Substances 0.000 abstract description 55
- 102000013142 Amylases Human genes 0.000 abstract description 55
- 108010065511 Amylases Proteins 0.000 abstract description 55
- 235000019418 amylase Nutrition 0.000 abstract description 55
- 239000013612 plasmid Substances 0.000 abstract description 21
- 241000588724 Escherichia coli Species 0.000 abstract description 12
- 210000004027 cell Anatomy 0.000 description 70
- 108090000623 proteins and genes Proteins 0.000 description 56
- 102000004190 Enzymes Human genes 0.000 description 45
- 108090000790 Enzymes Proteins 0.000 description 45
- 229940088598 enzyme Drugs 0.000 description 44
- 239000013598 vector Substances 0.000 description 38
- 108091026890 Coding region Proteins 0.000 description 26
- 108020004414 DNA Proteins 0.000 description 26
- 238000003752 polymerase chain reaction Methods 0.000 description 25
- 239000000243 solution Substances 0.000 description 24
- 239000000872 buffer Substances 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- 230000002538 fungal effect Effects 0.000 description 19
- 230000014509 gene expression Effects 0.000 description 19
- 239000000047 product Substances 0.000 description 19
- 102000004169 proteins and genes Human genes 0.000 description 19
- 235000018102 proteins Nutrition 0.000 description 18
- 108010076504 Protein Sorting Signals Proteins 0.000 description 17
- 239000013615 primer Substances 0.000 description 17
- 239000000523 sample Substances 0.000 description 17
- 108091028043 Nucleic acid sequence Proteins 0.000 description 16
- 240000006439 Aspergillus oryzae Species 0.000 description 15
- 238000003556 assay Methods 0.000 description 14
- 230000035772 mutation Effects 0.000 description 14
- 229940024606 amino acid Drugs 0.000 description 13
- 239000000203 mixture Substances 0.000 description 13
- 230000010076 replication Effects 0.000 description 12
- 241000228212 Aspergillus Species 0.000 description 11
- 241000235402 Rhizomucor Species 0.000 description 11
- 239000008186 active pharmaceutical agent Substances 0.000 description 11
- 239000003599 detergent Substances 0.000 description 11
- 230000010354 integration Effects 0.000 description 11
- 229920000856 Amylose Polymers 0.000 description 10
- 241000223218 Fusarium Species 0.000 description 10
- 108091005804 Peptidases Proteins 0.000 description 10
- 102000035195 Peptidases Human genes 0.000 description 10
- 230000007062 hydrolysis Effects 0.000 description 10
- 238000006460 hydrolysis reaction Methods 0.000 description 10
- 230000001105 regulatory effect Effects 0.000 description 10
- 239000006228 supernatant Substances 0.000 description 10
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 9
- 102100022624 Glucoamylase Human genes 0.000 description 9
- 229920002774 Maltodextrin Polymers 0.000 description 9
- 239000005913 Maltodextrin Substances 0.000 description 9
- 238000010367 cloning Methods 0.000 description 9
- 239000002299 complementary DNA Substances 0.000 description 9
- 229940035034 maltodextrin Drugs 0.000 description 9
- 239000000758 substrate Substances 0.000 description 9
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 8
- 239000004365 Protease Substances 0.000 description 8
- 235000019419 proteases Nutrition 0.000 description 8
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 8
- 241000228245 Aspergillus niger Species 0.000 description 7
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 7
- 239000000499 gel Substances 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 230000004048 modification Effects 0.000 description 7
- 238000012986 modification Methods 0.000 description 7
- 238000000746 purification Methods 0.000 description 7
- 108010075550 termamyl Proteins 0.000 description 7
- 238000013518 transcription Methods 0.000 description 7
- 230000035897 transcription Effects 0.000 description 7
- 230000014616 translation Effects 0.000 description 7
- 241000351920 Aspergillus nidulans Species 0.000 description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- 108010002747 Pfu DNA polymerase Proteins 0.000 description 6
- 241001044165 Psilus Species 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 108020004999 messenger RNA Proteins 0.000 description 6
- 230000008488 polyadenylation Effects 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 230000009466 transformation Effects 0.000 description 6
- 238000013519 translation Methods 0.000 description 6
- 101000757144 Aspergillus niger Glucoamylase Proteins 0.000 description 5
- 108010059892 Cellulase Proteins 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 108090001060 Lipase Proteins 0.000 description 5
- 102000004882 Lipase Human genes 0.000 description 5
- 239000004367 Lipase Substances 0.000 description 5
- 108091034117 Oligonucleotide Proteins 0.000 description 5
- 102000005924 Triose-Phosphate Isomerase Human genes 0.000 description 5
- 108700015934 Triose-phosphate isomerases Proteins 0.000 description 5
- 108010048241 acetamidase Proteins 0.000 description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 5
- 238000009835 boiling Methods 0.000 description 5
- 229940106157 cellulase Drugs 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 210000000349 chromosome Anatomy 0.000 description 5
- 238000002744 homologous recombination Methods 0.000 description 5
- 230000006801 homologous recombination Effects 0.000 description 5
- 235000019421 lipase Nutrition 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 4
- 108020004705 Codon Proteins 0.000 description 4
- 241000221779 Fusarium sambucinum Species 0.000 description 4
- 102000003992 Peroxidases Human genes 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 108040007629 peroxidase activity proteins Proteins 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 210000001938 protoplast Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 108010037870 Anthranilate Synthase Proteins 0.000 description 3
- 108091005658 Basic proteases Proteins 0.000 description 3
- 101710117655 Maltogenic alpha-amylase Proteins 0.000 description 3
- 239000012901 Milli-Q water Substances 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 3
- 235000011130 ammonium sulphate Nutrition 0.000 description 3
- 229960000723 ampicillin Drugs 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- -1 amyL Chemical class 0.000 description 3
- 229940025131 amylases Drugs 0.000 description 3
- 230000003625 amylolytic effect Effects 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 230000002759 chromosomal effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 239000013613 expression plasmid Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 230000003301 hydrolyzing effect Effects 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 238000002703 mutagenesis Methods 0.000 description 3
- 231100000350 mutagenesis Toxicity 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 150000002482 oligosaccharides Polymers 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 150000004804 polysaccharides Chemical class 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- XNPKNHHFCKSMRV-UHFFFAOYSA-N 4-(cyclohexylamino)butane-1-sulfonic acid Chemical compound OS(=O)(=O)CCCCNC1CCCCC1 XNPKNHHFCKSMRV-UHFFFAOYSA-N 0.000 description 2
- 101710146708 Acid alpha-amylase Proteins 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- 101000690713 Aspergillus niger Alpha-glucosidase Proteins 0.000 description 2
- 108090000145 Bacillolysin Proteins 0.000 description 2
- 108010029675 Bacillus licheniformis alpha-amylase Proteins 0.000 description 2
- 239000008000 CHES buffer Substances 0.000 description 2
- 102000010911 Enzyme Precursors Human genes 0.000 description 2
- 108010062466 Enzyme Precursors Proteins 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- 241000192125 Firmicutes Species 0.000 description 2
- 101100369308 Geobacillus stearothermophilus nprS gene Proteins 0.000 description 2
- 101100080316 Geobacillus stearothermophilus nprT gene Proteins 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- 101100295959 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) arcB gene Proteins 0.000 description 2
- MKWKNSIESPFAQN-UHFFFAOYSA-N N-cyclohexyl-2-aminoethanesulfonic acid Chemical compound OS(=O)(=O)CCNC1CCCCC1 MKWKNSIESPFAQN-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 238000002123 RNA extraction Methods 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 241000235403 Rhizomucor miehei Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 108010006785 Taq Polymerase Proteins 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 239000013504 Triton X-100 Substances 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 101150008194 argB gene Proteins 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 238000010804 cDNA synthesis Methods 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 229960005091 chloramphenicol Drugs 0.000 description 2
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 239000007979 citrate buffer Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000001351 cycling effect Effects 0.000 description 2
- 238000004851 dishwashing Methods 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 108010061330 glucan 1,4-alpha-maltohydrolase Proteins 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 238000001155 isoelectric focusing Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 101150039489 lysZ gene Proteins 0.000 description 2
- 101150095344 niaD gene Proteins 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 235000019833 protease Nutrition 0.000 description 2
- 101150054232 pyrG gene Proteins 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 239000012224 working solution Substances 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- IEQAICDLOKRSRL-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO IEQAICDLOKRSRL-UHFFFAOYSA-N 0.000 description 1
- OSBLTNPMIGYQGY-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;boric acid Chemical compound OB(O)O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O OSBLTNPMIGYQGY-UHFFFAOYSA-N 0.000 description 1
- QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 235000019890 Amylum Nutrition 0.000 description 1
- 241000534414 Anotopterus nikparini Species 0.000 description 1
- 108010017640 Aspartic Acid Proteases Proteins 0.000 description 1
- 101900127796 Aspergillus oryzae Glucoamylase Proteins 0.000 description 1
- 101000695691 Bacillus licheniformis Beta-lactamase Proteins 0.000 description 1
- 241000194107 Bacillus megaterium Species 0.000 description 1
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 1
- 108010023063 Bacto-peptone Proteins 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 108020004638 Circular DNA Proteins 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 229920002245 Dextrose equivalent Polymers 0.000 description 1
- 101100342470 Dictyostelium discoideum pkbA gene Proteins 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 101100385973 Escherichia coli (strain K12) cycA gene Proteins 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 241000145614 Fusarium bactridioides Species 0.000 description 1
- 241000223195 Fusarium graminearum Species 0.000 description 1
- 241000223221 Fusarium oxysporum Species 0.000 description 1
- 241000567178 Fusarium venenatum Species 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- 101100001650 Geobacillus stearothermophilus amyM gene Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000223198 Humicola Species 0.000 description 1
- 241001480714 Humicola insolens Species 0.000 description 1
- 102100027612 Kallikrein-11 Human genes 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- 108010029541 Laccase Proteins 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 108090000157 Metallothionein Proteins 0.000 description 1
- 241000235395 Mucor Species 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 108091005507 Neutral proteases Proteins 0.000 description 1
- 102000035092 Neutral proteases Human genes 0.000 description 1
- 108090000913 Nitrate Reductases Proteins 0.000 description 1
- 102000007981 Ornithine carbamoyltransferase Human genes 0.000 description 1
- 101710113020 Ornithine transcarbamylase, mitochondrial Proteins 0.000 description 1
- 102100037214 Orotidine 5'-phosphate decarboxylase Human genes 0.000 description 1
- 108010055012 Orotidine-5'-phosphate decarboxylase Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 238000011530 RNeasy Mini Kit Methods 0.000 description 1
- 101000968489 Rhizomucor miehei Lipase Proteins 0.000 description 1
- 241000235525 Rhizomucor pusillus Species 0.000 description 1
- 241000554265 Sphaerias Species 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 241000187432 Streptomyces coelicolor Species 0.000 description 1
- 101100370749 Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) trpC1 gene Proteins 0.000 description 1
- 241000187391 Streptomyces hygroscopicus Species 0.000 description 1
- 241000187398 Streptomyces lividans Species 0.000 description 1
- 241001468239 Streptomyces murinus Species 0.000 description 1
- 108090000787 Subtilisin Proteins 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000012505 Superdex™ Substances 0.000 description 1
- 239000008051 TBE buffer Substances 0.000 description 1
- 101100157012 Thermoanaerobacterium saccharolyticum (strain DSM 8691 / JW/SL-YS485) xynB gene Proteins 0.000 description 1
- 108010022394 Threonine synthase Proteins 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 101710152431 Trypsin-like protease Proteins 0.000 description 1
- 108091023045 Untranslated Region Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- IXKSXJFAGXLQOQ-XISFHERQSA-N WHWLQLKPGQPMY Chemical compound C([C@@H](C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CNC=N1 IXKSXJFAGXLQOQ-XISFHERQSA-N 0.000 description 1
- 229920002000 Xyloglucan Polymers 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 108010045649 agarase Proteins 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 238000012867 alanine scanning Methods 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 101150078331 ama-1 gene Proteins 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 101150009206 aprE gene Proteins 0.000 description 1
- 210000004507 artificial chromosome Anatomy 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- 230000010310 bacterial transformation Effects 0.000 description 1
- 101150103518 bar gene Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 238000013124 brewing process Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000037012 chymotrypsin-like activity Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- 101150005799 dagA gene Proteins 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000002050 diffraction method Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004362 fungal culture Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 210000005256 gram-negative cell Anatomy 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 108010002685 hygromycin-B kinase Proteins 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 101150105920 npr gene Proteins 0.000 description 1
- 101150017837 nprM gene Proteins 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000007981 phosphate-citrate buffer Substances 0.000 description 1
- 108010082527 phosphinothricin N-acetyltransferase Proteins 0.000 description 1
- 238000005222 photoaffinity labeling Methods 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 230000001124 posttranscriptional effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 101150108007 prs gene Proteins 0.000 description 1
- 101150086435 prs1 gene Proteins 0.000 description 1
- 101150070305 prsA gene Proteins 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012898 sample dilution Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000013595 supernatant sample Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 230000014621 translational initiation Effects 0.000 description 1
- 101150016309 trpC gene Proteins 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 101150110790 xylB gene Proteins 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
- C12N9/2411—Amylases
- C12N9/2414—Alpha-amylase (3.2.1.1.)
- C12N9/2417—Alpha-amylase (3.2.1.1.) from microbiological source
- C12N9/242—Fungal source
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
- A21D8/00—Methods for preparing or baking dough
- A21D8/02—Methods for preparing dough; Treating dough prior to baking
- A21D8/04—Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
- A21D8/042—Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes with enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12C—BEER; PREPARATION OF BEER BY FERMENTATION; PREPARATION OF MALT FOR MAKING BEER; PREPARATION OF HOPS FOR MAKING BEER
- C12C11/00—Fermentation processes for beer
- C12C11/003—Fermentation of beerwort
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
- C12N9/2411—Amylases
- C12N9/2414—Alpha-amylase (3.2.1.1.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/12—Disaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/14—Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M16/00—Biochemical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. enzymatic
- D06M16/003—Biochemical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. enzymatic with enzymes or microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01001—Alpha-amylase (3.2.1.1)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/10—Biofuels, e.g. bio-diesel
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Textile Engineering (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Jellies, Jams, And Syrups (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Fats And Perfumes (AREA)
- Heat Sensitive Colour Forming Recording (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200201928 | 2002-12-17 | ||
| PCT/DK2003/000882 WO2004055178A1 (en) | 2002-12-17 | 2003-12-16 | Thermostable alpha-amylases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006509511A JP2006509511A (ja) | 2006-03-23 |
| JP2006509511A5 JP2006509511A5 (enExample) | 2010-05-06 |
| JP4550587B2 true JP4550587B2 (ja) | 2010-09-22 |
Family
ID=32523927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004559633A Expired - Lifetime JP4550587B2 (ja) | 2002-12-17 | 2003-12-16 | 熱安定性α−アミラーゼ |
Country Status (10)
| Country | Link |
|---|---|
| US (7) | US7189552B2 (enExample) |
| EP (1) | EP1576152B1 (enExample) |
| JP (1) | JP4550587B2 (enExample) |
| CN (1) | CN100412191C (enExample) |
| AT (1) | ATE347591T1 (enExample) |
| AU (1) | AU2003287900A1 (enExample) |
| DE (1) | DE60310264T2 (enExample) |
| DK (1) | DK1576152T3 (enExample) |
| ES (1) | ES2278210T3 (enExample) |
| WO (1) | WO2004055178A1 (enExample) |
Families Citing this family (116)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60310264T2 (de) | 2002-12-17 | 2007-07-05 | Novozymes A/S | Thermostabile alpha-amylase |
| US7579177B2 (en) | 2003-05-30 | 2009-08-25 | Novozymes A/S | Alcohol product processes |
| BRPI0516653A2 (pt) * | 2004-12-02 | 2012-07-31 | Novozymes North America Inc | processo para desengomar um pano engomado contendo amido ou derivados de amido durante a manufatura de um pano |
| US8841091B2 (en) | 2004-12-22 | 2014-09-23 | Novozymes Als | Enzymes for starch processing |
| MX2007007107A (es) * | 2004-12-22 | 2007-08-08 | Novozymes North America Inc | Polipeptidos que tienen actividad de glucoamilasa y polinucleotidos que los codifican. |
| US20080138864A1 (en) * | 2004-12-22 | 2008-06-12 | Novozymes A/S | Starch Process |
| CN106397601A (zh) * | 2004-12-22 | 2017-02-15 | 诺维信公司 | 用于淀粉加工的酶 |
| WO2007076388A2 (en) | 2005-12-22 | 2007-07-05 | Novozymes North America, Inc. | Processes for producing a fermentation product |
| MX2009009967A (es) * | 2007-03-23 | 2009-10-07 | Danisco Us Inc Genencor Div | Produccion mejorada de amilasa por adicion n-terminal a proteina amilasa madura. |
| EP3219804B1 (en) | 2007-04-24 | 2019-07-17 | Novozymes North America, Inc. | Detoxifying pre-treated lignocellulose-containing materials |
| CN101796247B (zh) | 2007-09-03 | 2014-01-22 | 诺维信公司 | 脱毒和再循环在含木素纤维素材料的预处理中使用的洗涤溶液 |
| CA2726688A1 (en) | 2008-06-23 | 2010-01-21 | Novozymes A/S | Processes for producing fermentation products |
| US7666457B1 (en) | 2008-08-19 | 2010-02-23 | Delavau Llc | Dry mixes comprising glycerine |
| US20110165617A1 (en) | 2008-09-30 | 2011-07-07 | Novozymes North America, Inc. | Enzymatic Hydrolysis Of Pretreated Lignocellulose-Containing Material With Distillers Dried Grains |
| WO2010059413A2 (en) | 2008-11-20 | 2010-05-27 | Novozymes, Inc. | Polypeptides having amylolytic enhancing activity and polynucleotides encoding same |
| EP2384365A2 (en) | 2008-12-30 | 2011-11-09 | Novozymes North America, Inc. | Improvement of enzymatic hydrolysis of pretreated lignocellulose-containing material with dissolved air flotation sludge |
| WO2010078392A2 (en) | 2008-12-31 | 2010-07-08 | Novozymes North America, Inc. | Processes of producing fermentation products |
| EP2430169A2 (en) * | 2009-05-12 | 2012-03-21 | Danisco US Inc. | Ethanol yields in fermentation from an improved liquefaction process |
| CA2766720A1 (en) | 2009-07-07 | 2011-01-13 | Novozymes A/S | Process for treating a substrate with an enzyme |
| CA2768315A1 (en) | 2009-07-17 | 2011-01-20 | Novozymes A/S | A method of analyzing cellulose decay in cellulosic material hydrolysis |
| CN102647918B (zh) | 2009-08-07 | 2015-05-27 | 丹尼斯科美国公司 | 用于淀粉加工的α-淀粉酶混合物及其使用方法 |
| WO2011039324A1 (en) | 2009-09-30 | 2011-04-07 | Novozymes A/S | Steamed bread preparation methods and steamed bread improving compositions |
| US20110091938A1 (en) * | 2009-10-20 | 2011-04-21 | Grain Processing Corporation | Starch Hydrolysis |
| EP3434764B1 (en) | 2009-12-09 | 2026-04-08 | The Procter & Gamble Company | Fabric and home care products |
| CN102933227A (zh) | 2009-12-22 | 2013-02-13 | 诺维信公司 | 包含增强性多肽和淀粉降解酶的组合物及其用途 |
| EP2529022A1 (en) | 2010-01-29 | 2012-12-05 | Novozymes A/S | Biogas production process with enzymatic pre-treatment |
| WO2011100161A1 (en) | 2010-02-09 | 2011-08-18 | Novozymes North America, Inc. | Addition of alpha - glucosidase and cobalt for producing fermentation products from starch |
| CN102834521B (zh) | 2010-03-30 | 2018-02-27 | 诺维信公司 | 用于增强来自发酵工艺副产物的方法 |
| CA2802083C (en) | 2010-06-11 | 2018-10-09 | Novozymes A/S | Enzymatic flour correction |
| EP2601301A1 (en) | 2010-08-02 | 2013-06-12 | Novozymes North America, Inc. | Process of producing a fermentation product |
| CA2817224A1 (en) | 2010-11-19 | 2012-05-24 | Novozymes North America, Inc. | Processes of producing a fermentation product |
| CN103339260A (zh) | 2011-01-04 | 2013-10-02 | 诺维信公司 | 从含果胶和木素纤维素的材料产生生物气的方法 |
| US9677094B2 (en) | 2011-02-07 | 2017-06-13 | Novozymes A/S | Process of producing a fermentation product |
| CN102213716A (zh) * | 2011-04-07 | 2011-10-12 | 中国水产科学研究院东海水产研究所 | 一种用酶标法测定海马幼苗组织消化酶活力的方法 |
| CN103492579A (zh) | 2011-04-29 | 2014-01-01 | 丹尼斯科美国公司 | 用纤维素酶和葡糖淀粉酶提高发酵制备乙醇的产率 |
| WO2013000945A1 (en) | 2011-06-28 | 2013-01-03 | Novozymes A/S | Biogas from enzyme-treated bagasse |
| MX337984B (es) * | 2011-07-06 | 2016-03-30 | Novozymes As | Variantes de alfa amilasa y polinucleotidos que codifican la misma. |
| CN109022518A (zh) * | 2011-07-22 | 2018-12-18 | 诺维信北美公司 | 用于预处理纤维素材料和改进其水解的方法 |
| WO2013083801A2 (en) | 2011-12-09 | 2013-06-13 | Novozymes A/S | Biogas from substrates comprising animal manure and enzymes |
| WO2013096652A1 (en) | 2011-12-21 | 2013-06-27 | Novozymes, Inc. | Methods for determining the degradation of a biomass material |
| CA2869047C (en) | 2012-03-30 | 2022-11-01 | Novozymes North America, Inc. | Processes of producing fermentation products |
| US9828595B2 (en) | 2012-08-17 | 2017-11-28 | Novozymes A/S | Thermostable asparaginase variants and polynucleotides encoding same |
| CN103114049B (zh) * | 2013-01-29 | 2015-04-15 | 华东理工大学 | 一种共表达葡萄糖淀粉酶和α-淀粉酶的重组毕赤酵母菌株及其构建方法,以及混合酶制剂 |
| DK3022300T3 (en) | 2013-07-17 | 2018-10-22 | Novozymes As | : Pullulan chimeras and polynucleotides encoding them |
| WO2015057517A1 (en) | 2013-10-17 | 2015-04-23 | Danisco Us Inc. | Use of hemicellulases to improve ethanol production |
| EP3097192B1 (en) | 2014-01-22 | 2018-07-25 | Novozymes A/S | Pullulanase variants and polynucleotides encoding same |
| CA2937818C (en) | 2014-02-07 | 2023-08-01 | Novozymes A/S | Compositions for producing glucose syrups |
| WO2015143144A1 (en) | 2014-03-19 | 2015-09-24 | Novozymes A/S | Method for enhancing activity of an x143 polypeptide |
| WO2016062875A2 (en) | 2014-10-23 | 2016-04-28 | Novozymes A/S | Glucoamylase variants and polynucleotides encoding same |
| CN105695435A (zh) * | 2014-11-28 | 2016-06-22 | 华东理工大学 | 一种耐高温淀粉酶、其编码基因及其应用 |
| BR112017011275A2 (pt) | 2014-12-01 | 2018-04-03 | Novozymes A/S | composição, e, processo para a produção de xarope de glicose. |
| EP3872174B1 (en) | 2015-05-13 | 2023-03-01 | Danisco US Inc. | Aprl-clade protease variants and uses thereof |
| EP4234693A3 (en) | 2015-06-17 | 2023-11-01 | Danisco US Inc | Bacillus gibsonii-clade serine proteases |
| WO2017015329A1 (en) | 2015-07-23 | 2017-01-26 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
| JP6467656B2 (ja) * | 2015-07-29 | 2019-02-13 | 日油株式会社 | 製パン用油脂組成物 |
| EP4483721A3 (en) | 2015-11-05 | 2025-04-16 | Danisco US Inc. | Paenibacillus and bacillus spp. mannanases |
| JP7364331B2 (ja) | 2015-11-05 | 2023-10-18 | ダニスコ・ユーエス・インク | パエニバチルス(Paenibacillus)属種マンナナーゼ |
| CN108699543B (zh) | 2015-12-18 | 2023-07-14 | 丹尼斯科美国公司 | 具有内切葡聚糖酶活性的多肽及其用途 |
| US20190194636A1 (en) | 2016-05-03 | 2019-06-27 | Danisco Us Inc | Protease variants and uses thereof |
| WO2017192300A1 (en) | 2016-05-05 | 2017-11-09 | Danisco Us Inc | Protease variants and uses thereof |
| JP7609549B2 (ja) | 2016-05-31 | 2025-01-07 | ダニスコ・ユーエス・インク | プロテアーゼ変異体およびその使用 |
| CN109563497A (zh) | 2016-06-17 | 2019-04-02 | 丹尼斯科美国公司 | 蛋白酶变体及其用途 |
| WO2018085524A2 (en) | 2016-11-07 | 2018-05-11 | Danisco Us Inc | Laundry detergent composition |
| US20200392477A1 (en) | 2016-12-21 | 2020-12-17 | Danisco Us Inc. | Protease variants and uses thereof |
| CN110312794B (zh) | 2016-12-21 | 2024-04-12 | 丹尼斯科美国公司 | 吉氏芽孢杆菌进化枝丝氨酸蛋白酶 |
| EP3583210B1 (en) | 2017-03-15 | 2021-07-07 | Danisco US Inc. | Trypsin-like serine proteases and uses thereof |
| WO2018184004A1 (en) | 2017-03-31 | 2018-10-04 | Danisco Us Inc | Alpha-amylase combinatorial variants |
| EP3668973A2 (en) | 2017-08-18 | 2020-06-24 | Danisco US Inc. | Alpha-amylase variants |
| US20200354708A1 (en) | 2017-11-29 | 2020-11-12 | Danisco Us Inc. | Subtilisin variants having improved stability |
| CN112105729B (zh) | 2018-04-09 | 2024-05-14 | 诺维信公司 | 具有α-淀粉酶活性的多肽以及编码它们的多核苷酸 |
| EP3572512A1 (en) | 2018-05-24 | 2019-11-27 | B.R.A.I.N. Ag | A method for engineering a protein |
| EP3799601A1 (en) | 2018-06-19 | 2021-04-07 | Danisco US Inc. | Subtilisin variants |
| EP3810767B1 (en) | 2018-06-19 | 2026-07-15 | Danisco US Inc. | Subtilisin variants |
| WO2020028443A1 (en) | 2018-07-31 | 2020-02-06 | Danisco Us Inc | Variant alpha-amylases having amino acid substitutions that lower the pka of the general acid |
| EP3856882A1 (en) | 2018-09-27 | 2021-08-04 | Danisco US Inc. | Compositions for medical instrument cleaning |
| US20210355469A1 (en) | 2018-10-12 | 2021-11-18 | Danisco Us Inc | Alpha-amylases with mutations that improve stability in the presence of chelants |
| US12509672B2 (en) | 2018-11-28 | 2025-12-30 | Danisco Us Inc. | Subtilisin variants having improved stability |
| CN114174504B (zh) | 2019-05-24 | 2026-04-17 | 丹尼斯科美国公司 | 枯草杆菌蛋白酶变体和使用方法 |
| EP3980517A1 (en) | 2019-06-06 | 2022-04-13 | Danisco US Inc. | Methods and compositions for cleaning |
| BR112022007697A2 (pt) | 2019-10-24 | 2022-07-12 | Danisco Us Inc | Alfa-amilase variante que forma maltopentaose/maltohexaose |
| CN116323935A (zh) | 2020-08-27 | 2023-06-23 | 丹尼斯科美国公司 | 用于清洁的酶和酶组合物 |
| EP4284906A1 (en) | 2021-01-29 | 2023-12-06 | Danisco US Inc. | Compositions for cleaning and methods related thereto |
| CN113151220A (zh) * | 2021-04-29 | 2021-07-23 | 广州博识生物科技有限公司 | 一种耐酸α-淀粉酶 |
| CN113201518A (zh) * | 2021-04-29 | 2021-08-03 | 广州博识生物科技有限公司 | 一种高活性α-淀粉酶 |
| WO2023278297A1 (en) | 2021-06-30 | 2023-01-05 | Danisco Us Inc | Variant lipases and uses thereof |
| CN117916354A (zh) | 2021-09-03 | 2024-04-19 | 丹尼斯科美国公司 | 用于清洁的衣物洗涤组合物 |
| CN118647716A (zh) | 2021-12-16 | 2024-09-13 | 丹尼斯科美国公司 | 成麦芽五糖/麦芽六糖变体α-淀粉酶 |
| US20250051748A1 (en) | 2021-12-16 | 2025-02-13 | Danisco Us Inc. | Subtilisin variants and methods of use |
| EP4448750A2 (en) | 2021-12-16 | 2024-10-23 | Danisco US Inc. | Subtilisin variants and uses thereof |
| CN118679252A (zh) | 2021-12-16 | 2024-09-20 | 丹尼斯科美国公司 | 枯草杆菌蛋白酶变体和使用方法 |
| EP4486858A1 (en) | 2022-03-01 | 2025-01-08 | Danisco US Inc. | Enzymes and enzyme compositions for cleaning |
| EP4544016A1 (en) | 2022-06-21 | 2025-04-30 | Danisco US Inc. | Methods and compositions for cleaning comprising a polypeptide having thermolysin activity |
| CN119855892A (zh) | 2022-09-02 | 2025-04-18 | 丹尼斯科美国公司 | 洗涤剂组合物及其相关方法 |
| EP4581137A1 (en) | 2022-09-02 | 2025-07-09 | Danisco Us Inc | Mannanase variants and methods of use |
| CN120112635A (zh) | 2022-09-02 | 2025-06-06 | 丹尼斯科美国公司 | 枯草杆菌蛋白酶变体及其相关方法 |
| EP4608147A1 (en) | 2022-10-24 | 2025-09-03 | Novozymes A/S | Baking method with thermostable amg variant and alpha-amylase |
| JP2026514204A (ja) | 2022-10-28 | 2026-05-07 | ノボザイムス アクティーゼルスカブ | 植物性食品成分を得るための方法 |
| CN120303400A (zh) | 2022-11-09 | 2025-07-11 | 丹尼斯科美国公司 | 枯草杆菌蛋白酶变体和使用方法 |
| CN120283060A (zh) | 2022-12-19 | 2025-07-08 | 诺维信公司 | 用于使用纤维降解酶和工程化酵母生产发酵产物的工艺 |
| CN120380140A (zh) | 2022-12-19 | 2025-07-25 | 诺维信公司 | 具有阿魏酸酯酶和/或乙酰木聚糖酯酶活性的碳水化合物酯酶家族1(ce1)多肽和编码其的多核苷酸 |
| EP4638767A1 (en) | 2022-12-19 | 2025-10-29 | Novozymes A/S | Process for reducing syrup viscosity in the backend of a process for producing a fermentation product |
| WO2024137248A1 (en) | 2022-12-19 | 2024-06-27 | Novozymes A/S | Compositions comprising arabinofuranosidases and a xylanase, and use thereof for increasing hemicellulosic fiber solubilization |
| EP4638725A1 (en) | 2022-12-19 | 2025-10-29 | Novozymes A/S | Carbohydrate esterase family 3 (ce3) polypeptides having acetyl xylan esterase activity and polynucleotides encoding same |
| EP4658776A1 (en) | 2023-02-01 | 2025-12-10 | Danisco US Inc. | Subtilisin variants and methods of use |
| WO2024186819A1 (en) | 2023-03-06 | 2024-09-12 | Danisco Us Inc. | Subtilisin variants and methods of use |
| CN120813242A (zh) | 2023-03-16 | 2025-10-17 | 营养与生物科学美国第四公司 | 用于清洁和臭味控制的短芽孢杆菌发酵物提取物及其用途 |
| AU2024303961A1 (en) | 2023-06-13 | 2025-12-11 | Novozymes A/S | Processes for producing fermentation products using engineered yeast expressing a beta-xylosidase |
| WO2025032096A1 (en) | 2023-08-09 | 2025-02-13 | Novozymes A/S | Methods for obtaining a plant-based food ingredient |
| WO2025071996A1 (en) | 2023-09-28 | 2025-04-03 | Danisco Us Inc. | Variant cutinase enzymes with improved solubility and uses thereof |
| WO2025085351A1 (en) | 2023-10-20 | 2025-04-24 | Danisco Us Inc. | Subtilisin variants and methods of use |
| WO2025128568A1 (en) | 2023-12-11 | 2025-06-19 | Novozymes A/S | Composition and use thereof for increasing hemicellulosic fiber solubilization |
| WO2026008449A2 (en) | 2024-07-04 | 2026-01-08 | Novozymes A/S | A process for producing a fermentation product and a concentrated protein co-product |
| WO2026024922A1 (en) | 2024-07-25 | 2026-01-29 | Danisco Us Inc. | Subtilisin variants and methods of use |
| WO2026050315A1 (en) | 2024-08-29 | 2026-03-05 | Danisco Us Inc. | Subtilisin variants and methods of use |
| WO2026128766A1 (en) | 2024-12-13 | 2026-06-18 | Danisco Usa Inc. | Malodor control compostions comprising bacterial fermentate extracts and methods related thereof |
| WO2026128769A1 (en) | 2024-12-13 | 2026-06-18 | Danisco Usa Inc. | Cleaning compositions comprising bacterial fermentate extracts and methods related thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3582020D1 (de) * | 1984-11-09 | 1991-04-11 | Hitachi Ltd | Thermostabile alpha-amylase produzierende thermostabile anaerobe bakterie, thermostabile alpha-amylase und verfahren zur deren herstellung. |
| DK122686D0 (da) | 1986-03-17 | 1986-03-17 | Novo Industri As | Fremstilling af proteiner |
| DE3909096A1 (de) | 1989-03-20 | 1990-09-27 | Garabed Antranikian | Alpha-amylase |
| CA2156302A1 (en) | 1993-02-19 | 1994-09-01 | STEEN TROELS JõRGENSEN | An amylolytic enzyme |
| JPH09503916A (ja) | 1993-10-08 | 1997-04-22 | ノボ ノルディスク アクティーゼルスカブ | アミラーゼ変異体 |
| ES2250969T3 (es) | 1994-03-29 | 2006-04-16 | Novozymes A/S | Amilasa alcalina de bacilo. |
| GB9413419D0 (en) * | 1994-07-04 | 1994-08-24 | Danisco | Amylase enzyme |
| MX9705906A (es) | 1995-02-03 | 1997-10-31 | Novo Nordisk As | Un metodo para diseñar mutantes de alfa-amilasa con propiedades predeterminadas. |
| AR000862A1 (es) | 1995-02-03 | 1997-08-06 | Novozymes As | Variantes de una ó-amilasa madre, un metodo para producir la misma, una estructura de adn y un vector de expresion, una celula transformada por dichaestructura de adn y vector, un aditivo para detergente, composicion detergente, una composicion para lavado de ropa y una composicion para la eliminacion del |
| ATE317005T1 (de) | 1996-03-27 | 2006-02-15 | Novozymes As | Alkaline-phosphatase-defiziente, filamentöse pilze |
| AR029759A1 (es) * | 1999-07-09 | 2003-07-16 | Novozymes As | Variante de glucoamilasa original, una construccion de adn, un vector de expresion recombinante, una celula, un proceso para convertir almidon, uso de una variante de glucoamilasa para un proceso de fermentacion y metodo para mejorar la estabilidad termica. |
| US7005288B1 (en) * | 1999-11-10 | 2006-02-28 | Novozymes A/S | Fungamyl-like alpha-amylase variants |
| WO2001034784A1 (en) * | 1999-11-10 | 2001-05-17 | Novozymes A/S | Fungamyl-like alpha-amylase variants |
| ES2613277T3 (es) * | 2001-02-21 | 2017-05-23 | Basf Enzymes Llc | Enzimas que tienen actividad de alfa amilasa y métodos de uso de las mismas. |
| DE60310264T2 (de) * | 2002-12-17 | 2007-07-05 | Novozymes A/S | Thermostabile alpha-amylase |
-
2003
- 2003-12-16 DE DE60310264T patent/DE60310264T2/de not_active Expired - Lifetime
- 2003-12-16 CN CNB2003801065145A patent/CN100412191C/zh not_active Expired - Lifetime
- 2003-12-16 DK DK03779740T patent/DK1576152T3/da active
- 2003-12-16 WO PCT/DK2003/000882 patent/WO2004055178A1/en not_active Ceased
- 2003-12-16 JP JP2004559633A patent/JP4550587B2/ja not_active Expired - Lifetime
- 2003-12-16 AT AT03779740T patent/ATE347591T1/de not_active IP Right Cessation
- 2003-12-16 ES ES03779740T patent/ES2278210T3/es not_active Expired - Lifetime
- 2003-12-16 US US10/539,396 patent/US7189552B2/en not_active Expired - Lifetime
- 2003-12-16 AU AU2003287900A patent/AU2003287900A1/en not_active Abandoned
- 2003-12-16 EP EP03779740A patent/EP1576152B1/en not_active Expired - Lifetime
-
2007
- 2007-02-06 US US11/671,692 patent/US20070190608A1/en not_active Abandoned
-
2008
- 2008-02-25 US US12/036,806 patent/US20080220476A1/en not_active Abandoned
-
2010
- 2010-04-06 US US12/755,076 patent/US8039241B2/en not_active Expired - Lifetime
-
2011
- 2011-09-13 US US13/230,984 patent/US20120003700A1/en not_active Abandoned
-
2014
- 2014-03-31 US US14/231,062 patent/US9394533B2/en not_active Expired - Fee Related
-
2016
- 2016-04-06 US US15/092,044 patent/US9938512B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ATE347591T1 (de) | 2006-12-15 |
| US20160208230A1 (en) | 2016-07-21 |
| US9938512B2 (en) | 2018-04-10 |
| US20060051849A1 (en) | 2006-03-09 |
| WO2004055178A9 (en) | 2004-10-07 |
| JP2006509511A (ja) | 2006-03-23 |
| ES2278210T3 (es) | 2007-08-01 |
| EP1576152B1 (en) | 2006-12-06 |
| DK1576152T3 (da) | 2007-04-10 |
| US7189552B2 (en) | 2007-03-13 |
| US9394533B2 (en) | 2016-07-19 |
| CN1726280A (zh) | 2006-01-25 |
| US8039241B2 (en) | 2011-10-18 |
| AU2003287900A1 (en) | 2004-07-09 |
| EP1576152A1 (en) | 2005-09-21 |
| WO2004055178A1 (en) | 2004-07-01 |
| US20100209996A1 (en) | 2010-08-19 |
| US20140206045A1 (en) | 2014-07-24 |
| DE60310264T2 (de) | 2007-07-05 |
| AU2003287900A8 (en) | 2004-07-09 |
| US20070190608A1 (en) | 2007-08-16 |
| CN100412191C (zh) | 2008-08-20 |
| US20120003700A1 (en) | 2012-01-05 |
| US20080220476A1 (en) | 2008-09-11 |
| DE60310264D1 (en) | 2007-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006509511A (ja) | 熱安定性α−アミラーゼ | |
| CA2452029C (en) | A group of .alpha.-amylases and a method for identification and production of .alpha.-amylases | |
| CN101939421B (zh) | 嗜热脂肪芽孢杆菌α-淀粉酶的变体及其用途 | |
| EP2121910A1 (en) | Alpha-amylase and its use | |
| JP2001520006A (ja) | α−アミラーゼ変異体 | |
| JPH06217770A (ja) | プルラナーゼ、それを生産する微生物、そのプルラナーゼの調製方法及び使用 | |
| KR20120052263A (ko) | β?아밀라제를 이용한 식품의 개질 방법 | |
| EP0833927A1 (en) | Gene encoding alkaline liquefying alpha-amylase | |
| JP2007532117A (ja) | αアミラーゼ変異体 | |
| MX2008016444A (es) | Polipeptido. | |
| KR100545010B1 (ko) | 트리펩티딜 아미노펩티다제 생산의 감소 또는 제거 방법 | |
| AU629959B2 (en) | Mutant enzyme having reduced stability under industrial application conditions | |
| US7005288B1 (en) | Fungamyl-like alpha-amylase variants | |
| JP7649547B2 (ja) | 新規βアミラーゼ及びその利用・製造法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20061205 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080513 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20091215 |
|
| A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20100315 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100608 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100708 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 4550587 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130716 Year of fee payment: 3 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |